Skip to content

The value of body composition analysis in disease evaluation

The value of body composition analysis in disease evaluation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082205
Enrollment
Unknown
Registered
2024-03-22
Start date
2024-03-27
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and Obesity

Interventions

Different diagnosis group:N/A

Sponsors

the First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) Obese or overweight patients visit the integrated diagnosis and treatment center for obesity from July 2022 to December 2023; (2) Patients who have completed the assessment of body composition through bioelectrical impedance analysis; (3) Patients who are older than or equal to 18 years.

Exclusion criteria

Exclusion criteria: Patients who have cognitive impairment or mental illness.

Design outcomes

Primary

MeasureTime frame
Body composition;

Secondary

MeasureTime frame
Blood routine examination;Lipid profile;Serum biochemical parameter;

Countries

China

Contacts

Public ContactChen Huihe

the First Affiliated Hospital of Guangxi Medical University

cy50cent@qq.com+86 177 5867 8697

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026